Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # Hoffmann-La Roche
  • # DNA
  • # Johnson&Johnson
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Immunoglobulin (Antibody) – Structure and Types

19 July 2023

Reduced risks of common diseases through the inherited predisposition for higher muscle strength

16 April 2024

MicroRNA (miRNA) – An Overview on Structure and its Working

18 October 2024

An improved prime editing system can do gene-sized edits in human cells at therapeutic levels

13 June 2024

mAb Capture Made Cost Effective and Productive With Cytiva’s Protein A Resins

8 April 2025

Researchers found the impact on hormone levels in mice by gut microbiome

30 September 2024

New drugs for antibiotic-resistant bacteria, developed using generative AI

31 March 2024

Lilly to Offer All Approved Doses of Zepbound (tirzepatide) in Single-Dose Vials Through LillyDirect

16 June 2025

Researchers developed lipid nanoparticles for netter mRNA therapies

23 November 2024

A newly designed drug candidate can make pancreatic cancer treatable

7 March 2024

Researchers developed a functional human brain tissue by the 3D-printing technology

2 February 2024

Gene variants of Neanderthal associated with greater pain sensitivity; University College London

4 November 2023

GSK

GSK Acquires Efimosfermin, Bolstering Liver Disease Pipeline with Potential Best-in-Class Treatment
Business Healthcare & Pharmaceuticals News

GSK Acquires Efimosfermin, Bolstering Liver Disease Pipeline with Potential Best-in-Class Treatment

Ajmal Aseem 8 July 2025

GSK has finalized its acquisition of efimosfermin, a promising new therapeutic for steatotic liver disease. The deal, valued at up to $2 billion, positions GSK to potentially launch a best-in-class treatment for MASH and ALD by 2029, significantly enhancing its hepatology portfolio.

GSK Announces Early Discontinuation of Phase III PIVOT-PO Study for Tebipenem HBr Due to Positive Efficacy Results
Clinical Trials Healthcare & Pharmaceuticals News

GSK Announces Early Discontinuation of Phase III PIVOT-PO Study for Tebipenem HBr Due to Positive Efficacy Results

Ajmal Aseem 29 May 2025

GSK has halted its Phase III PIVOT-PO trial early after an independent review confirmed tebipenem HBr met its primary efficacy goal in treating complicated urinary tract infections, marking a major step forward for oral antibiotic options.

GSK’s Blenrep Combinations Approved in Japan for Relapsed or Refractory Multiple Myeloma
Healthcare & Pharmaceuticals News Regulatory Approval

GSK’s Blenrep Combinations Approved in Japan for Relapsed or Refractory Multiple Myeloma

Ajmal Aseem 20 May 2025

GSK’s Blenrep combinations have been approved in Japan for treating relapsed or refractory multiple myeloma, following strong Phase III trial results demonstrating improved survival outcomes.

GSK Released EMBRACE a Phase 2b Clinical Trial Data of an Investigational Broadly Neutralising Antibody for HIV
Business Clinical Trials Healthcare & Pharmaceuticals News

GSK Released EMBRACE a Phase 2b Clinical Trial Data of an Investigational Broadly Neutralising Antibody for HIV

Editor's Desk 18 March 2025

The findings support the increasing amount of data showing that N6LS is a strong antiviral that may be used as part of an all-encompassing antiretroviral treatment plan.

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Cytiva Hiring a Quality Control Technician in Cardiff, United Kingdom
  • PhD Position in Dialysis Therapy – University of Twente, Netherlands
  • Eli Lilly and Company Hiring a Analytical Technical Steward-Peptides in Hyderabad, India – June, 2025
  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
SciRealityPress BiotechReality

A SciRealityPress Associate

DMCA.com Protection Status

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy